Healthcare >> Analyst Interviews >> June 20, 2014

Consolidation in Medical Devices Sector Replacing R&D and Product Launches

Brozak, Steve
Steve Brozak is the Managing Partner & President of WBB Securities, LLC, an investment bank and financial analytical firm engaged in the pharmaceutical, biotechnology and medical device sectors. Mr. Brozak has actively followed the evolving health care space over the last two decades. He has written about and advised multiple companies over the years. Mr. Brozak has also written several health-care-related pieces, including “A 21st Century Nosocomial Issue with Endoscopes” published in the British Medical Journal. Additional pieces written by Mr. Brozak include “Seeking Innovation: Incentive Funding for Biodefense Biotechs Biosecurity and Bioterrorism” in Biodefense Strategy, Practice, and Science; “Long Shadow of the Stem-Cell Ruling: The Bankers” in Nature; “Caution – FDA Could Be, Hazardous to our Health” in Food and Drug Law Journal; and “Fighting Epidemics With Venture Capital” on Bloomberg Government. Mr. Brozak is frequently quoted by major news organizations and has been an invited speaker at numerous industry gatherings. The Wall Street Journal named Mr. Brozak as the "Best on the Street" Financial Analyst for the medical equipment and supplies category in its 19th Annual Best on the Street survey. In 2013, Mr. Brozak was a top-ranked Analyst in the pharmaceutical industry based on his 12-month performance returns by the Thomson Reuters and StarMine, and is also a top-ranked Biotech Analyst. Mr. Brozak is a retired Lieutenant Colonel in the United States Marine Corps and now serves on the Secretary of the Navy's Navy and Marine Corps Retiree Council, where he focuses on health care. Mr. Brozak holds a B.A. and MBA from Columbia University. Profile
TWST: Medical devices seems to be a very active area. What’s going on; what’s spurring the consolidation?

Mr. Brozak: What you’re seeing is not just in medical devices